TRIO Pharmaceuticals
CA - San CarlosPharmaceutical
Focus: TRIO Pharmaceuticals is a publicly traded company headquartered in San Carlos, CA, focused on cancer immunotherapeutics with programs spanning oncology and neurology. The company operates at early clinical stages with minimal disclosed revenue or employee count.
Profile data last refreshed 16h ago · AI intelligence enriched 21h ago
Funding Stage
PUBLIC
Total Funding
$300M
Open Jobs
1
Should You Work at TRIO Pharmaceuticals?
AI assessmentTRIO presents a speculative early-stage opportunity for immuno-oncology specialists willing to accept execution risk in exchange for equity upside, but severely limited hiring and opaque financials suggest caution.
Why Work Here
- Public company status provides equity upside and career visibility in the immuno-oncology space
- Focus on cancer immunotherapeutics aligns with high-growth therapeutic area attracting top talent
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Help build intelligence for TRIO Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.